News from the FDA/CDC
News from the FDA/CDC
Latuda receives FDA approval for adolescent schizophrenia treatment
The FDA has approved lurasidone HCI (Latuda) for treating schizophrenia in adolescents aged 13-17.
News from the FDA/CDC
Smoking-cessation interest and success vary by race, ethnicity
Just over 55% of adult cigarette smokers made an attempt to quit in the past year, and 7.4% said that they recently quit.
News from the FDA/CDC
Most cigarette smokers attempt to quit without evidence-based techniques
More than half of cigarette smokers have received advice to quit from a health care professional, but less than a third used medication or...
News from the FDA/CDC
Fewer people having problems with medical bills
The number of people under age 65 years who were in families having trouble paying medical bills dropped by more than 22% from 2011 to 2016,...
News from the FDA/CDC
FDA eases mental health warnings in smoking cessation drugs’ labels
Labels on the smoking cessation drugs varenicline and bupropion will offer less severe warnings for mental health risk potentials in people with...
News from the FDA/CDC
Latest CDC data: Opioid deaths still rising
The U.S. death rate from synthetic opioids, including fentanyl, soared by 72.2% from 2014 to 2015, according to the CDC.
News from the FDA/CDC
FDA warning: General anesthetics may damage young brains
FDA warning says repeated or lengthy use of general anesthetic or sedation drugs under age 3 years or in late pregnancy may affect children’s...
News from the FDA/CDC
Four of five health care providers get flu shot
Physicians had the highest level of coverage (95.6%), while health care assistants and aides had the lowest (64.5%).